INMB
INmune Bio Inc
2.00$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 4.2% | 54,209.4% | 11,349.7% | 4,563.4% | 13,079.4% | 236,900.0% | 41,318.0% | |
| – | – | – | – | 7.7% | 57,906.7% | 4,856.9% | 2,475.4% | 6,208.4% | 67,735.7% | 20,520.0% | |
| – | – | – | – | 10.0% | 112,116.1% | 16,206.6% | 7,038.8% | 19,287.7% | 304,635.7% | 61,838.0% | |
| – | – | – | – | -10.0% | -112,016.1% | -16,106.6% | -6,938.8% | -19,187.7% | -304,535.7% | -61,738.0% | |
| – | – | – | – | 0.0% | 0.0% | 655.8% | 360.4% | – | – | – | |
| – | – | – | – | -9.9% | -110,838.8% | -16,762.4% | -7,299.2% | -19,360.0% | -300,585.7% | -91,866.0% | |
| – | – | – | – | 1.9% | -1,177.3% | 655.8% | 360.4% | -19,187.7% | – | – | |
| – | – | – | – | -9.9% | -110,838.8% | -16,762.4% | -7,659.6% | -19,360.0% | -300,585.7% | -91,866.0% | |
| – | – | – | – | -9.9% | -112,016.1% | -16,762.4% | -7,299.2% | -172.3% | -296,635.7% | -91,698.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.